H. Tiede

发表

Response to letters regarding article, "Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)".

R. Speich, S. Rosenkranz, J. Behr, 2014, Circulation.

Short-Term Improvement in Pulmonary Hemodynamics is Strongly Predictive of Long-Term Survival in Patients with Pulmonary Arterial Hypertension

W. Seeger, H. Ghofrani, N. Weissmann, 2013, Pulmonary circulation.

Pulmonary hypertension: Hemodynamic evaluation. Updated Recommendations of the Cologne Consensus Conference 2011.

R. Blindt, S. Rosenkranz, R. Ewert, 2011, International journal of cardiology.

Long-term effects of intravenous iloprost in patients with idiopathic pulmonary arterial hypertension deteriorating on non-parenteral therapy

H. Ghofrani, R. Ewert, H. Klose, 2011, BMC pulmonary medicine.

Air travel can be safe and well tolerated in patients with clinically stable pulmonary hypertension

W. Seeger, H. Ghofrani, F. Grimminger, 2011, Pulmonary circulation.

Anticoagulation and Survival in Pulmonary Arterial Hypertension: Results from the COMPERA Registry

R. Speich, S. Rosenkranz, J. Behr, 2013 .

Dynamische Hyperinflation bei der pulmonal arteriellen Hypertonie: „Hyperinflator“ und „Non-Hyperinflator“

W. Seeger, H. Ghofrani, F. Reichenberger, 2013, Pneumologie.

Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations

W. Seeger, C. Fischer, F. Reichenberger, 2011, Respiratory research.

The Prognostic Significance of Inspiratory Capacity in Pulmonary Arterial Hypertension

W. Seeger, H. Ghofrani, F. Reichenberger, 2014, Respiration.

Heart Rate Variability is Related to Disease Severity in Children and Young Adults with Pulmonary Hypertension

W. Seeger, D. Schranz, A. Ghofrani, 2015, Front. Pediatr..

[Obstructive sleep apnea and stroke].

B. Rosengarten, R. Schulz, R. Dumitrascu, 2012, Pneumologie.

Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis.

W. Kuebler, H. Ghofrani, R. Schermuly, 2014, American journal of respiratory and critical care medicine.

Economic Evaluation of Exercise Training in Patients with Pulmonary Hypertension

S. Rosenkranz, H. Klose, C. Opitz, 2014, Lung.

Methods and Results—We analyzed data from Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA), an ongoing European pulmonary hypertension registry. Survival rates of patients with IPAH

R. Speich, S. Rosenkranz, H. Ghofrani, 2013 .

COMPERA Registry Anticoagulation and Survival in Pulmonary Arterial Hypertension: Results from the

S. Rosenkranz, J. Behr, R. Ewert, 2013 .

[Mental distress and wish for psychosomatic treatment of patients with pulmonary hypertension].

M. de Zwaan, M. Hoeper, K. Olsson, 2014, Psychotherapie, Psychosomatik, medizinische Psychologie.

Interaction of ambrisentan and phenprocoumon in patients with pulmonary hypertension.

H. Ghofrani, N. Sommer, H. Tiede, 2014, Pulmonary pharmacology & therapeutics.

Efficacy of exercise training in pulmonary arterial hypertension associated with congenital heart disease.

R. Speich, C. Fischer, M. Lichtblau, 2013, International journal of cardiology.

Anticoagulation and Survival in Pulmonary Arterial Hypertension: Results From the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)

R. Speich, S. Rosenkranz, J. Behr, 2013, Circulation.

Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertension.

L. Huson, H. Ghofrani, R. Schermuly, 2013, American journal of respiratory and critical care medicine.

Assessment and Prognostic Relevance of Right Ventricular Contractile Reserve in Patients With Severe Pulmonary Hypertension

C. Fischer, R. Naeije, E. Bossone, 2013, Circulation.

Cardiovocal Syndrome (Ortner's Syndrome) Associated with Chronic Thromboembolic Pulmonary Hypertension and Giant Pulmonary Artery Aneurysm: Case Report and Review of the Literature

G. Krombach, A. Ghofrani, J. Klussmann, 2012, Case reports in medicine.

Dynamic hyperinflation during exercise in patients with precapillary pulmonary hypertension.

W. Seeger, H. Ghofrani, F. Reichenberger, 2011, Respiratory medicine.

Quality of life in clinically stable adult cystic fibrosis out-patients: associations with daytime sleepiness and sleep quality.

W. Seeger, F. Reichenberger, K. Mayer, 2012, Respiratory medicine.

Exercise training in pulmonary arterial hypertension associated with connective tissue diseases

C. Fischer, M. Lichtblau, F. Reichenberger, 2012, Arthritis Research & Therapy.

Poor sleep quality is associated with exercise limitation in precapillary pulmonary hypertension

W. Seeger, H. Ghofrani, J. Heitmann, 2015, BMC Pulmonary Medicine.

Sleep apnea in precapillary pulmonary hypertension.

W. Seeger, H. Ghofrani, J. Heitmann, 2013, Sleep medicine.

Global burden of chronic thromboembolic pulmonary hypertension (CTEPH): An epidemiological analysis

M. Richter, M. Hoeper, W. Cacheris, 2014 .

Usefulness of serial N-terminal pro-B-type natriuretic peptide measurements for determining prognosis in patients with pulmonary arterial hypertension.

D. Rizopoulos, N. Westerhof, P. Eilers, 2011, The American journal of cardiology.

HbA1c in pulmonary arterial hypertension: a marker of prognostic relevance?

W. Seeger, H. Ghofrani, F. Reichenberger, 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Management of chronic thromboembolic pulmonary hypertension (CTEPH): A physician-based perception study

I. Preston, B. Hinzmann, H. Tiede, 2012 .

Quality of life in clinically stable adult cystic fibrosis out-patients: associations with daytime sleepiness and sleep quality

W. Seeger, F. Reichenberger, K. Mayer, 2012 .

Dynamic hyperinflation during exercise in patients with precapillary pulmonary hypertension.

W. Seeger, H. Ghofrani, F. Reichenberger, 2012, Respiratory medicine.

Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertension.

L. Huson, H. Ghofrani, R. Schermuly, 2013, American journal of respiratory and critical care medicine.